• Français

Centre de recherche
Friday, June 28 2019

$150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects

IRIC is proud to announce $150,000 in funding from the Richard and Edith Strauss Foundation for two promising cancer research projects.

For the “Identification of biological targets influencing the response to anti-AML drugs” project, Dr. Guy Sauvageau received $100,000 in funding. As for Dr. Sonia Cellot, Paediatric hematologist at CHU Sainte-Justine, and Brian Wilhelm, they received $50,000 in financial support for their project titled “Characterising the stem/progenitor cell of origin of high fatality pediatric leukemia”.

IRIC warmly thanks the Foundation for its dedication to the cause.

About the projects

Acute myeloid leukemia (AML) is a heterogeneous disease defined by various subtypes of AML that respond differently to available treatments and for which prognosis varies. Dr. Sauvageau’s group has identified compounds, glucocorticoids and ABT-199 that selectively target poor prognosis AML subtypes. However, not all leukemias from these subgroups respond to treatment. The project aims to shed light on the mechanisms responsible for resistance to treatment with glucocorticoids or ABT-199, to ultimately develop optimised therapies involving these drugs.

Despite the common feature of acute leukemias of presenting uncontrolled cell growth, the genetic errors causing the disease are complex and vary from one patient to another, regardless of age. For instance, a specific group of leukemias containing chromosomal translocations more frequently affects young children than adults. Even though it is known that blood stem cells undergo changes with aging, it is still not clear what all of these changes are, nor how they influence the development of a leukemia. The project led by Brian Wilhelm and Dr. Sonia Cellot aims to use leading-edge new technologies to study the genome of tens of thousands of individual cells at the same time. The objective is to better define the changes that occur in the DNA of young and old stem cells by using their human model leukemia system to test how these changes impact leukemia development. The research project will help better identify the types of drugs that might be useful for the treatment of specific leukemias.

For information


Persons mentioned in the text
About this page
Updated on 6/28/2019
Created on 6/28/2019
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931


© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security


Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine